ReP USP - Resultado da busca

Filtros : "Financiamento FAPESP" "NEOPLASIAS" "Giarolla, Jeanine" Limpar

Filtros

Artigo de periodico
Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception (2025)
Giarolla, Jeanine ; Holdaway, Kelsey A ; Nazari, Maryam; Aiad, Laila; Sarkar, Bidisha; Georg, Gunda I
Source: Future Medicinal Chemistry. Unidade: FCF
Subjects: LIGANTES, NEOPLASIAS, ENSAIO CLÍNICO, LIGANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIAROLLA, Jeanine et al. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry, v. 17, n. 5, p. 607–627, 2025Tradução . . Disponível em: https://dx.doi.org/10.1080/17568919.2025.2463868. Acesso em: 08 out. 2025.
APA
Giarolla, J., Holdaway, K. A., Nazari, M., Aiad, L., Sarkar, B., & Georg, G. I. (2025). Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry, 17( 5), 607–627. doi:10.1080/17568919.2025.2463868
NLM
Giarolla J, Holdaway KA, Nazari M, Aiad L, Sarkar B, Georg GI. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception [Internet]. Future Medicinal Chemistry. 2025 ; 17( 5): 607–627.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1080/17568919.2025.2463868
Vancouver
Giarolla J, Holdaway KA, Nazari M, Aiad L, Sarkar B, Georg GI. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception [Internet]. Future Medicinal Chemistry. 2025 ; 17( 5): 607–627.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1080/17568919.2025.2463868
Parte de monografia/livro
Advances in targeted dendrimers for cancer therapy and challenges for clinical translation (2021)
Silva, João Vitor da ; Santos, Soraya da Silva ; Sanches, Luccas Missfeldt ; Ferreira, Elizabeth Igne ; Giarolla, Jeanine
Source: Dendrimer-Based Nanotherapeutics. Unidade: FCF
Subjects: MACROMOLÉCULA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, João Vitor da et al. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation. Dendrimer-Based Nanotherapeutics. Tradução . Waltham: Elsevier, 2021. . Disponível em: https://doi.org/10.1016/B978-0-12-821250-9.00003-2. Acesso em: 08 out. 2025.
APA
Silva, J. V. da, Santos, S. da S., Sanches, L. M., Ferreira, E. I., & Giarolla, J. (2021). Advances in targeted dendrimers for cancer therapy and challenges for clinical translation. In Dendrimer-Based Nanotherapeutics. Waltham: Elsevier. doi:10.1016/B978-0-12-821250-9.00003-2
NLM
Silva JV da, Santos S da S, Sanches LM, Ferreira EI, Giarolla J. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation [Internet]. In: Dendrimer-Based Nanotherapeutics. Waltham: Elsevier; 2021. [citado 2025 out. 08 ] Available from: https://doi.org/10.1016/B978-0-12-821250-9.00003-2
Vancouver
Silva JV da, Santos S da S, Sanches LM, Ferreira EI, Giarolla J. Advances in targeted dendrimers for cancer therapy and challenges for clinical translation [Internet]. In: Dendrimer-Based Nanotherapeutics. Waltham: Elsevier; 2021. [citado 2025 out. 08 ] Available from: https://doi.org/10.1016/B978-0-12-821250-9.00003-2

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2025